iCare Launches ALTIUS: The Game-Changing Cloud Platform Redefining Eye Care Imaging

September 16, 2025 at 10:45 AM EDT

iCare USA, a global innovator in eye care diagnostics, proudly unveils the launch of iCare ALTIUS™, a sleek cloud platform that’s set to disrupt how eye care professionals capture, manage, and share diagnostic images.

Built for speed and designed for clarity, iCare ALTIUS changes the status quo of on-premise servers and clunky workflows. Hosted on a secure, HIPAA-compliant AWS backbone, this platform delivers instant access to diagnostic images and patient data—whether you’re in the clinic, at home, or on the go.

ALTIUS is more than a storage solution—it's a fully integrated imaging experience. With automated image uploads, dynamic timelines, flicker tools, and side-by-side comparisons, clinicians can quickly spot subtle changes that might otherwise go unnoticed.

“Adding iCare ALTIUS has allowed my practice to take review of retinal health to the next level,” says John Warren, OD. “Seamless cloud review, automated functions, and ease of use make iCare ALTIUS ideal for any busy eye care practice looking for a secure, HIPAA compliant image management software.”

Why ALTIUS Stands Out:

No installs, no stress—just log in and go
Automatic image uploads straight from iCare devices
Visual patient timelines and smart annotation tools
Flicker and mosaic comparison for disease progression insights
Perfect for multi-location practices and connected care models

Ready to take your eye care data to the cloud? Visit https://www.icare-world.com/us/product/icare-altius/ to learn more.

About iCare USA

iCare USA is a trusted partner offering cutting-edge technology to aid in diagnosing and screening ocular diseases. The ease of use and operational reliability are the cornerstones of iCare’s success. The iCare product line consists of medical devices for retinal imaging, fundus perimetry, and rebound tonometry. For more information, contact infousa@icare-world.com or visit icare-world.com.

About iCare

iCare is a Finnish company that develops and manufactures innovative hand-held tonometers, fundus imaging devices, perimeters and software solutions for the diagnosis and screening of eye diseases. iCare's vision is to keep the world visible to everyone, and its goal is to facilitate the identification and treatment of eye diseases through its technological solutions. iCare is part of Helsinki Stock Exchange listed Revenio Group Corporation.

About Revenio Group

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. In 2023, the Group’s net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.